General Information of the Compound
Compound ID
CP0313434
Compound Name
4-(2-propan-2-yl-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepin-3-yl)benzonitrile
    Show/Hide
Structure
Formula
C17H20N4
Molecular Weight
280.375
Canonical SMILES
CC(C)n1nc2CCNCCc2c1-c1ccc(cc1)C#N
    Show/Hide
InChI
InChI=1S/C17H20N4/c1-12(2)21-17(14-5-3-13(11-18)4-6-14)15-7-9-19-10-8-16(15)20-21/h3-6,12,19H,7-10H2,1-2H3
    Show/Hide
InChIKey
DYBWPBGEFFIVCW-UHFFFAOYSA-N
Physicochemical Property
logP
2.69088
Rotatable Bonds
2
Heavy Atom Count
21
Polar Areas
53.64
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11380477
SID: 16474250
ChEMBL ID
CHEMBL4743582
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01746, 5-hydroxytryptamine receptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 90 nM
   TI
   LI
   LO
   TS